| 商品名称 | Comfortis |
|---|---|
| 适用类别 | Veterinary |
| 治疗领域 | |
| 通用名/非专利名称 | spinosad |
| 活性成分 | spinosad |
| 产品号 | EMEA/V/C/002233 |
| 患者安全信息 | No |
| 许可状态 | Withdrawn |
| ATC编码 | QP53BX03 |
| 是否额外监管 | No |
| 是否仿制药或hybrid药物 | No |
| 是否生物类似药 | No |
| 是否附条件批准 | No |
| 是否特殊情形 | No |
| 是否加速审评 | No |
| 是否罕用药 | No |
| 上市许可日期 | 2011/02/11 |
| 上市许可开发者/申请人/持有人 | Elanco GmbH |
| 人用药物治疗学分组 | |
| 兽用药物治疗学分组 | Other ectoparasiticides for systemic use |
| 审评意见日期 | 2010/12/08 |
| 欧盟委员会决定日期 | 2021/09/10 |
| 修订号 | 12 |
| 治疗适应症 | Treatment and prevention of flea infestations (Ctenocephalides felis). The preventive effect against re-infestations is a result of the adulticidal activity and the reduction in egg production and persists for up to 4 weeks after a single administration of the product. The veterinary medicinal product can be used as part of a treatment strategy for the control of flea allergy dermatitis (FAD). |
| 适用物种 | Dogs;Cats |
| 兽用药物ATC编码 | QP53BX03 |
| 首次发布日期 | 2016/01/07 |
| 最后更新日期 | 2023/06/26 |
| 产品说明书 | https://www.ema.europa.eu/en/documents/product-information/comfortis-epar-product-information_en.pdf |
| 公共评估报告 | https://www.ema.europa.eu/en/medicines/veterinary/EPAR/comfortis |